IDrugs. 2009 Dec;12(12):750-3.

Ubiquitin Drug Discovery & Diagnostics 2009 - First Annual Conference.

Source

Progenra Inc, 271A Great Valley Parkway, Malvern, PA 19355, USA. marblestone@progenra.com

Abstract

The Ubiquitin Drug Discovery & Diagnostics conference, held in Philadelphia, included topics covering new therapeutic developments in the field of ubiquitin drug research. This conference report highlights selected presentations on emerging ubiquitin targets in oncology and on proteasome inhibitor therapy for the treatment of multiple myeloma. Investigational drugs discussed include MLN-4924 and MLN-9708 (both Millennium Pharmaceuticals Inc), P-005091 (Progenra Inc), CEP-18770 (Cephalon Inc) and carfilzomib (Proteolix Inc).

PMID:: 19943215; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Supplemental Content

Related citations

AACR-NCI-EORTC--21st International Symposium. Molecular targets and cancer therapeutics--Part 2. [IDrugs. 2010]
AACR-NCI-EORTC--21st International Symposium. Molecular targets and cancer therapeutics--Part 2.
Walker K, Padhiar M. IDrugs. 2010 Jan; 13(1):10-2.
AACR-NCI-EORTC--21st International Symposium. Molecular targets and cancer therapeutics--Part 1. [IDrugs. 2010]
AACR-NCI-EORTC--21st International Symposium. Molecular targets and cancer therapeutics--Part 1.
Walker K, Padhiar M. IDrugs. 2010 Jan; 13(1):7-9.
International Drug Discovery Science and Technology--BIT's Seventh Annual Congress. [IDrugs. 2010]
International Drug Discovery Science and Technology--BIT's Seventh Annual Congress.
Bodovitz S. IDrugs. 2010 Jan; 13(1):23-5.
Review The potential of proteasome inhibitors in cancer therapy. [Expert Opin Investig Drugs. 2008]
Review The potential of proteasome inhibitors in cancer therapy.
Sterz J, von Metzler I, Hahne JC, Lamottke B, Rademacher J, Heider U, Terpos E, Sezer O. Expert Opin Investig Drugs. 2008 Jun; 17(6):879-95.
Review Targeting the ubiquitin-proteasome pathway in cancer therapy. [Anticancer Agents Med Chem. 2007]
Review Targeting the ubiquitin-proteasome pathway in cancer therapy.
Ishii Y, Waxman S, Germain D. Anticancer Agents Med Chem. 2007 May; 7(3):359-65.

See reviews... See all...

Cited by 1 PubMed Central article

Characterisation of the Trichinella spiralis deubiquitinating enzyme, TsUCH37, an evolutionarily conserved proteasome interaction partner. [PLoS Negl Trop Dis. 2011]
Characterisation of the Trichinella spiralis deubiquitinating enzyme, TsUCH37, an evolutionarily conserved proteasome interaction partner.
White RR, Miyata S, Papa E, Spooner E, Gounaris K, Selkirk ME, Artavanis-Tsakonas K. PLoS Negl Trop Dis. 2011 Oct; 5(10):e1340. Epub 2011 Oct 4.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Ubiquitin Drug Discovery & Diagnostics 2009 - First Annual Conference.
Ubiquitin Drug Discovery & Diagnostics 2009 - First Annual Conference.
IDrugs. 2009 Dec ;12(12):750-3.

PubMed
Autonomic peripheral neuropathy.
Autonomic peripheral neuropathy.
Neurol Clin. 2007 Feb ;25(1):277-301.

PubMed
Cytotoxic T cell responses against mesothelioma by apoptotic cell-pulsed dendrit...
Cytotoxic T cell responses against mesothelioma by apoptotic cell-pulsed dendritic cells.
Am J Respir Crit Care Med. 2004 Jun 15 ;169(12):1322-30. Epub 2004 Apr 7 .

PubMed
Characterization of histone (H1B) oxalate binding protein in experimental urolit...
Characterization of histone (H1B) oxalate binding protein in experimental urolithiasis and bioinformatics approach to study its oxalate interaction.
Biochem Biophys Res Commun. 2006 Jun 23 ;345(1):345-54. Epub 2006 Apr 27 .

PubMed
Modulation of Caenorhabditis elegans transcription factor activity by HIM-8 and ...
Modulation of Caenorhabditis elegans transcription factor activity by HIM-8 and the related Zinc-Finger ZIM proteins.
Genetics. 2007 Oct ;177(2):1221-6. Epub 2007 Aug 24 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Ubiquitin Drug Discovery & Diagnostics 2009 - First Annual Conference.

Source

Abstract

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Other Literature Sources

Supplemental Content

Related citations

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information